Prolactin (PRL) is required not only for maintenance of gestation in pigs but also for mammary gland development and subsequent lactogenesis. The actions of PRL are modulated by both long and short isoforms of the PRL receptor (PRLR), where short isoforms can interfere with the essential signaling function of the long isoform. Using 3 0 RACE we have isolated a unique splice variant of the porcine PRLR (pPRLR) that contains a short intracellular domain of 38 aa that is encoded by splicing from exon 9 to a novel exon 11 located 17 . 5 kb downstream of exon 10 on chromosome 16. The short pPRLR was detected as a 42 kDa protein in membranes from porcine mammary glands. Functional analyses indicated that the short pPRLR functions as a dominant negative against the differentiative function of the long pPRLR and does not transduce a signal to the rat b-casein promoter. Differential abundance of long pPRLR and short pPRLR mRNA was established in a range of porcine tissues. The binding affinity of the short pPRLR for pPRL was lower (K d Z3 . 7 nM) than the affinity of the long pPRLR (K d Z1 . 6 nM) despite a fourfold higher level of binding sites for the short pPRLR. Our data raise the possibility that the short pPRLR in pigs may function independently from the long pPRLR, where the splicing strategy used to generate the short pPRLR likely evolved under different selection pressures to those acting on the long pPRLR.
Introduction
Prolactin (PRL) is a 23 kDa polypeptide hormone, which is derived principally from the anterior pituitary and has more than 300 biological functions, including a major systemic role in reproduction and lactation (Bole-Feysot et al. 1998 , Bachelot & Binart 2007 . A vital role exists for PRL during reproduction in pigs as pituitary PRL is required to maintain the corpora lutea, and therefore gestation (Anderson et al. 1967 , Forsyth 1986 . PRL also has a crucial role during mammary gland growth and lactation in this species (Farmer et al. 1998 , Farmer & Petitclerc 2003 .
The PRL receptor (PRLR) is a member of the large class 1 cytokine receptor superfamily (Bole-Feysot et al. 1998) . Each molecule of its dimer comprises an extracellular ligand-binding domain, a transmembrane domain, and an intracellular domain (Kelly et al. 1989) . Different isoforms of the PRLR have been named for the length of their intracellular domain generated by alternative splicing at the 3 0 end of the PRLR gene (Ormandy et al. 1998) . The porcine PRLR long form (LF) containing full-length exon 10 has been characterized (Trott et al. 2007) , where the LF transduces both mitogenic and differentiative signals in all species studied to date (Lesueur et al. 1991 , O'Neal & Yu-Lee 1994 , Jabbour et al. 1998 , Llovera et al. 2000 . Recently, we identified two short isoforms of the human PRLR (hPRLR-short form (SF); Trott et al. 2003) , generated by alternative splicing to exon 11, that extends its observation in other species including the rat (Boutin et al. 1988 ), mouse (Davis & Linzer 1989) , sheep and goat (Bignon et al. 1997) , cow , and carp (San Martin et al. 2007 ). The PRLR-SF share common features including a truncated intracellular domain, and function either as heterodimers with the PRLR-LF or as PRLR-SF homodimers. In the former case, heterodimerization of the PRLR-SF with the PRLR-LF confers a dominant-negative function that eliminates dimerization of the intracellular domain and prevents activation of downstream signaling molecules including Jak2 and Stat5 (Saunier et al. 2003 , Binart et al. 2010 . However, several lines of evidence also suggest that PRLR-SF may function independently of the PRLR-LF through different mechanisms. For example, the hPRLR-SF1b accelerates hPRLR-LF mRNA degradation two-to three-fold (Tan & Walker 2010) . Second, when 3T3 fibroblasts were transfected with one short form of the mouse Prlr (mPrlr-PR1) they proliferated in response to PRL, suggesting that this mPRLR-SF isoform transduced a mitogenic signal in the absence of the mPRLR-LF (Das & Vonderhaar 1995) . The mPRLR-PR1 also represses Forkhead box O3 (Foxo3) and galactose-1-phosphate uridyltransferase (Galt) expression in the mouse ovary, leading to premature follicular death (Halperin et al. 2008) . Finally, failure of heterozygous Prlr knockout (PRLRKO) mice to lactate after their first pregnancy can be rescued by overexpression of mPRLR-PR1 in the mammary gland (Binart et al. 2003) .
In this study, we aimed to identify any short isoforms of the PRLR in pigs using 3' RACE. Given our identification of a novel exon 11 in the pPRLR gene and a short isoform, we then sought to establish its expression in vivo and function in vitro.
Materials and methods

Animals and tissues
Crossbred New Hampshire!Yorkshire (F1) nulliparous and pregnant (day 105 of gestation) gilts were housed at the University of California, Davis. The animals had free access to water and were fed a corn and soybean mash (14 . 52% CP, 3168 kcal/kg ME, 0 . 6997% w/w lysine, 2 kg/day). Gilts were heat-checked daily to detect standing estrus in the presence of a mature boar and were then bred via artificial insemination. At necropsy, tissue samples were collected, snap frozen in liquid nitrogen, and stored at K80 8C. Samples from nulliparous pigs were collected from the adrenal glands, adipose tissue (back fat), endometrium, heart, hypothalamus, kidney, liver, lymph node, mammary gland, ovary, pancreas, pituitary, small intestine, skeletal muscle, spleen, stomach, thymus, and thyroid. In addition, we collected placenta, mammary gland, and endometrium from day 105 pregnant gilts. Experiments were performed in accordance with the NIH Guide for The Care and Use of Laboratory Animals, as approved by the UC Davis Institutional Animal Care and Use Committee.
Pregnant unilateral hysterectomy-ovariectomy (UHO) gilts at day 105 of gestation were housed, treated, killed, and their tissues were harvested as previously described (Freking et al. 2007 , Trott et al. 2009 ). These animals were used only for mammary gland membrane protein preparations.
3 0 RACE 3 0 RACE was performed on poly AC RNA from the porcine mammary gland and endometrium at day 105 of gestation using the SMARTer RACE cDNA amplification kit (Clontech, Mountain View, CA, USA). Two 5 0 genespecific primers were designed from the pPRLR-LF cDNA (GenBank Accession NM_001001868). These primers were GSP2a (5 0 -TGTCCAGGTTCGCTGCAA-GCCGG-3 0 ) in exon 7 and NGSP2a (5 0 -AGCATG-GTGGCCTGCATCCTTCCG-3 0 ) that spanned exons 8 and 9. These 5 0 primers were used in two rounds of nested PCR per the manufacturer's instructions; 3 0 RACE products from the nested PCR were identified by electrophoresis on 0 . 9% agarose gels, gel-purified, and cloned into pCR2.1 (Invitrogen, Carlsbad, CA, USA) prior to sequencing.
Cloning of the porcine PRLR-SF
We used primers in exons 5 and 11 to amplify a 1055 bp fragment of pPRLR-SF (pPRLR-SF 5P2 5 0 -TCATCACAGT-GAACGCCACGA-3 0 ; pPRLR-SF 3P2 5 0 -ATGGATGC-CATGCCAGGTG-3 0 ) by PCR using 2! ThermoPrime Plus (ThermoScientific, Rockford, IL, USA). Reaction conditions were 95 8C for 2 min, followed by 40 cycles of 95 8C for 15 s, 60 8C for 30 s, and 72 8C for 2 min. The PCR product was gel-purified, cloned into pCR2.1 TOPO (Invitrogen), and sequence verified. A 409 bp fragment of exons 3-5 that overlapped the pPRLR-SF ex5/11 PCR product was excised from pCR2.1 pPRLR-LF-FLAG (Trott et al. 2007) using BamHI, gel-purified, and ligated into pCR2.1 pPRLR-SF ex5/11 to create the full-length coding sequence of pPRLR-SF in pCR2.1. The correct orientation of the exons 3-5 insertion was confirmed using digestion with NdeI and KpnI followed by sequencing.
Generation of FLAG-tagged porcine PRLR-SF
To introduce a C-terminal FLAG epitope tag and create a pPRLR-SF-FLAG expression construct, primers were positioned upstream of the ATG translation initiation site (pPRLR-SF-FLAG 5P; 5 0 -CGGCGGTACCTCT-GACCCACTGCCTGTGGAAAG-3 0 ) and at the 3 0 end of the coding sequence (pPRLR-SF-FLAG2 3P; 5 0 -GCCCGAATTCTTATTTATCGTCATCGTCTTTG-TAGTCTGGTAAGAGGCATCCAACAGCAT-3 0 ) with a FLAG coding sequence (in bold) inserted prior to the stop codon. Restriction enzyme sites (underlined) were included to facilitate directional sub-cloning of the product. The pPRLR-SF-FLAG product was amplified from 10 ng of pCR2.1 pPRLF-SF plasmid template using the Advantage 2 PCR kit (Clontech). Reaction conditions were 94 8C for 2 min, followed by 5 cycles of 94 8C for 30 s, 55 8C for 30 s, and 72 8C for 90 s, followed by 35 cycles of 95 8C for 20 s and 68 8C for 2 min. The PCR product (972 bp) was gel-purified, cloned into pCR2.1-TOPO, and sequenced. One clone of the correct sequence was subcloned into the pEF4A (Invitrogen) expression vector using KpnI and EcoRI and sequence verified.
(pCMV)-enhanced green fluorescent protein (eGFP) contains eGFP cDNA under control of the pCMV (a gift from David Kerr, University of Vermont).
Reverse transcription and real-time quantitative PCR
RNA extraction and reverse transcription (RT) were performed as described previously (Trott et al. 2009 ). The sequences of primers and probes used to quantify pPRLR-LF mRNA, pPRLR-SF mRNA, and 18S rRNA expression levels are listed in Table 1 . Reversetranscribed cDNA template was amplified by quantitative PCR (Q-PCR) using Taqman Gene Expression PCR Master Mix (Applied Biosystems, Foster City, CA, USA), 0 . 9 mmol/l primers, and 0 . 2 mmol/l probe.
Reactions were performed on a 7500 Fast Real-Time PCR System (Applied Biosystems) using cycling conditions of 50 8C for 2 min, 95 8C for 10 min, then 40 cycles of 95 8C for 15 s and 60 8C for 1 min. Reactions were always prepared in duplicates and a negative control was included on each plate. The level of both pPRLR-LF mRNA and pPRLR-SF mRNA expression was normalized to the corresponding level of 18S rRNA using standard curves. An absolute quantification standard curve for pPRLR-SF mRNA was prepared from tenfold serial dilutions of an RT reaction prepared using a porcine liver RNA sample (17 . 9 endogenous copies of pPRLR-SF/mg RNA spiked with 25!10 9 copies of pCR2.1 pPRLF-SF plasmid DNA). The liver cDNA contributed 0 . 8 copies of pPRLR-SF to the standard curve stock tube containing 10 9 copies/PCR and was included so that the standard curve was of a comparable composition to the samples that were being assayed. The standard curve had a detection limit of 1 copy/ reaction and a linear range from 1 to 10 9 copies. An absolute quantification standard curve for pPRLR-LF mRNA was prepared from tenfold serial dilutions of a RT reaction of mouse liver RNA spiked with 25!10 9 copies of pcDNA3 pPRLF-LF-FLAG plasmid. Mouse liver RNA was used for this approach given that porcine liver RNA contained an excessive abundance of pPRLR-LF mRNA. The standard curve had a detection limit of 1 copy/reaction and a linear range from 5 to 10 9 copies. A relative standard curve for 18S rRNA was prepared using fivefold serial dilutions (nZ6) of a RT reaction. The same standard curve was used across multiple plates for each gene and was dispensed in duplicate or triplicate. Standard curves were generated by linear regression using C t versus log (dilution factor). All standard curves had a linear regression coeffcient of determination of at least 99 . 4%.
The pPRLR and 18S rRNA levels in each sample were calculated from the C t values using the standard curve. The relative 18S rRNA expression levels were normalized to an average expression of 1 for each plate. The average pPRLR data were divided by the average 18S rRNA expression level for each sample.
Cell culture
Chinese hamster ovary cells (CHO-K1) were cultured as described previously (Trott et al. 2003) . To examine PRLR signaling to the b-casein promoter, CHO-K1 cells were plated into 12-well plates at 1!10 5 cells/well the day before transfection. Each well was transfected with 0 . 2 mg PRLR and/or empty vector (pEF6C) DNA, 0 . 2 mg bcasLuc DNA, and 0 . 2 mg pCMV-eGFP DNA with 0 . 6 ml PLUS reagent and 1 . 8 ml Lipofectamine LTX (Invitrogen). When different ratios of pPRLR-LF:pPRLR-SF were examined, a constant amount of pPRLR-LF cDNA and variable amounts of pPRLR-SF cDNA were used with empty vector making up a total of 0 . 2 mg DNA. Cells were transfected for 24 h before the medium was changed to a-MEM supplemented with ITSC1 (BD Biosciences, Bedford, MA, USA), penicillin, streptomycin, and dexamethasone (1 mM; Sigma-Aldrich, St Louis, MO, USA) with or without porcine PRL (pPRL; 250 ng/ml; National Hormone and Peptide Program, Torrance, CA, USA). After 24 h, the cells were scraped into 200 ml of Glo Lysis buffer (Promega, Madison, WI, USA) and assayed for luciferase activity. Transfection efficiencies were controlled by co-transfection with pCMV-eGFP. The eGFP activity was measured in 150 ml cell lysate, using a black clearbottomed 96-well plate (Corning, Corning, NY, USA) and fluorescence was measured for 1 s at 485/520 nm. The luciferase activity measured in 50 ml cell lysate was normalized against the relative fluorescence level of eGFP in each lysate.
To examine protein expression of pPRLR isoforms, 8 . 5!10 5 cells were plated into a 25 cm 2 flask and transfected the next day with 4 mg DNA and 15 ml Attractene, or cells were plated and transfected as for the b-casein promoter assays. Media were changed to fresh growth media 16-24 h post transfection and cells were harvested 48 h post transfection. 
Western blot analysis
Transfected CHO-K1 cells were harvested and sonicated in the homogenization buffer (25 mM Tris pH 75, 2 mM MgCl 2 , 1 mM EDTA, 1 mM dithiothreitol, 1% Triton X-100, 1 mM leupeptin, 1 mM pepstatin A, 1 mg/ml aprotinin, 10 mg/ml soybean trypsin inhibitor, and 20 mg/ml phenylmethylsulphonyl fluoride). Porcine mammary gland membranes were prepared from two UHO pigs at 105 day of gestation as described earlier (Trott et al. 2009 ). Protein concentrations were determined against BSA standards using Coomassie Protein Assay Reagent (Pierce, Rockford, IL, USA). Total proteins were denatured, resolved under reducing conditions using 10% SDS-PAGE, and transferred to Immobilon (Millipore, Billerica, MA, USA).
Membranes were blocked with 0 . 5% nonfat milk in Tris-buffered saline plus 0 . 1% Tween-20. FLAG-tagged PRLR were detected with the SNAP I.D. system (Millipore) using either a mouse a-FLAG M2 monoclonal HRP conjugate (Sigma-Aldrich) or a mouse a-hPRLR-extracellular domain (ECD) monoclonal antibody (Zymed, Carlsbad, CA, USA) followed by an HRP-conjugated donkey a-mouse antibody ( Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA 
Phylogeny of PRLR
We aligned 17 PRLR-LF aa sequences to generate a phylogenetic tree from the following species using ClustalW (Larkin et al. 2007 
Results
Cloning and expression of the pPRLR-SF Using 3 0 RACE we identified two 900 bp clones from mammary gland tissue that contained cDNA sequence of exon 9 of the pPRLR that spliced to a novel sequence that we nominally identified as exon 11. RT-PCR on porcine mammary gland RNA using primers in exons 3 and 11, exons 4 and 11, exons 6 and 11, and exons 9 and 11 confirmed that this novel exon 11 was spliced downstream of exons 3-9 (data not shown). A search of the porcine genomic sequence available from ENSEMBL (Sscrofa9 April 2009 assembly; http:// uswest.ensembl.org/Sus_scrofa/Info/Index) revealed this exon 11 was located 17 458 bp downstream of exon 10 of the pPRLR, which is similar to human, rat, and mouse PRLR genomic structures where exon 11 is 15 . 1 kb (Trott et al. 2003), 19 . 5 kb (GenBank Accession NC_005101.2), and 12 kb downstream (GenBank Accession NW_001030567) respectively. Using 3 0 RACE we also identified a transcript of exon 10 that is 939 bp longer than previously published (GenBank Accession HM059030; Fig. 1 ). Figure 1 depicts the splicing strategy and genomic structure of the pPRLR coding exons, spanning 37 . 8 kb on the complementary strand of chromosome 16. The intron/ exon boundaries followed the AG/GT rule of Mount (1982) and were determined from the porcine genomic sequence, 5 0 RACE sequences (data not shown; Trott et al. 2007 ), pPRLR-SF cDNA (GenBank Accession GQ370382), and exon 10 sequence (GenBank Accession HM059030). The DNA sequence of exon 11 is shown in Fig. 2 along with a comparison of the amino acid sequence of the intracellular domains of pPRLR-LF and pPRLR-SF. The polyadenylation signal in exon 11 (TATAAA) is the third most common signal found in human genes (Beaudoing et al. 2000) . The G (in bold) immediately 5 0 to the poly-A tail is part of the adenylation sequence ( Fig. 2; Jin & Bian 2004 ). We found non-A bases at the start of the adenylation sequence in most of the 3 0 RACE sequences (data not shown). There are two regions of the intracellular tail of the PRLR that are conserved in all species; box 1, which is 8 aa of mostly prolines and hydrophobic residues, is found in all isoforms and box 2, which is rich in both hydrophobic and acidic amino acid , Bole-Feysot et al. 1998 , is found in all long and intermediate isoforms, the hPRLR-SF1a (Trott et al. 2003) , and both carp short PRLR isoforms (GenBank Accessions DQ086117 and DQ086116), but not in long form PRLR2 from tilapia (Fiol et al. 2009 ) or PRLR2 from Nile tilapia (Zhang et al. 2010) . The pPRLR-SF, like the majority of short isoforms, does contain box 1 but does not contain box 2 (Figs 1 and 2) . The full-length cDNA of pPRLR-SF with a C-terminal FLAG epitope was expressed in CHO-K1 cells. Both anti-hPRLR and anti-FLAG antibodies detected two pPRLR-SF proteins of 47 and 45 kDa in total cell protein extracts (Fig. 3) . A protein doublet (87 and 92 kDa) also arises from expression of pPRLR-LF in CHO-K1 cells (Fig. 3A) . In contrast, only one protein size was detected for both pPRLR-SF (42 kDa) and pPRLR-LF (95 kDa; Fig. 3D ) in pig mammary gland membrane protein extracts. The predicted size of pPRLR-SF from the amino acid sequence is 34 kDa (http://ca.expasy.org/tools/pi_tool.html) and the size differences are likely due to glycosylation of the protein (Trott et al. 2007 ). There was an average of 2 . 5 times more pPRLR-LF compared with pPRLR-SF in membrane proteins isolated from the mammary glands of two females at day 105 of gestation. We further examined the expression of pPRLR-SF using Q-PCR to determine which tissues express this isoform and the level of its expression compared with that of pPRLR-LF. There was expression of pPRLR-SF in all tissues except the thyroid (Fig. 4) . The level of expression in 18 tissues was on average 34 copies of pPRLR-SF mRNA/mg total RNA while the average level of expression of pPRLR-LF mRNA in 19 tissues was w1000-fold higher with 32!10 3 copies/mg total RNA. The tissues with at least 50 copies of pPRLR-SF mRNA expression/mg total RNA were the hypothalamus, adrenal gland, heart, ovary, small intestine, and spleen, while the tissues with the highest levels of pPRLR-LF mRNA (O50 000 copies/mg total RNA) were the adrenal gland, kidney, and mammary gland.
Ligand binding to pPRLR-SF
We previously found that different hPRLR-SF, which vary in their intracellular domain length and sequence, have a different ligand-binding capacity and/or affinity for lactogens compared with the hPRLR-LF (Trott et al. 2003) . We therefore used transient transfection of CHO-K1 cells with pPRLR-LF and pPRLR-SF to compare their binding affinity for pPRL (Fig. 5) . The binding affinity of pPRLR-LF for pPRL (K d Z1 . 6 nM; 95% confidence interval (CI) 1 . 0-2 . 7 nM; R 2 Z0 . 92) was higher than that of pPRLR-SF (K d Z3 . 7 nM; 95% CI 2 . 7-5 . 1 nM; R 2 Z0 . 97; P!0 . 0001). The B max for pPRLR-SF was 386 000 c.p.m. compared with 93 000 c.p.m. for the pPRLR-LF (P!0 . 0001), indicating a fourfold higher number of PRL binding sites for pPRLR-SF, even though the level of protein expression was similar (Fig. 3A) .
Lactogenic signaling via the pPRLR
Previous work on PRLR-SF isoforms found that some act as a dominant negative against the differentiative signaling by the PRLR-LF while others have been found to function independently of the PRLR-LF (Binart et al. 2010) . We examined the ability of the pPRLR-SF to transduce a differentiation signal to the b-casein promoter. When the pPRLR-LF was activated by pPRL in the presence of insulin and dexamethasone, it induced a five-to six-fold induction of activity from the b-casein promoter, whereas the pPRLR-SF was without effect (Fig. 6) . When the pPRLR-SF was co-transfected with the pPRLR-LF, lactogenic activity was completely inhibited when sixfold more pPRLR-SF was introduced (P!0 . 05). The addition of more pPRLR-SF to the same level of pPRLR-LF increases the total binding capacity of transfected CHO-K1 while simultaneously decreasing the ability of the pPRLR-LF to activate the b-casein promoter (Fig. 6 ) without affecting the level of pPRLR-LF protein (data not shown). The increase in specific binding is not additive, but this may be due to limitations of the binding assay.
Discussion
The splicing structure of the pPRLR-SF coding sequence involves alternative splicing from exons 9 to 11 of the PRLR gene, which is the same as for the human (Trott et al. 2003) , mouse (Ormandy et al. 1998) , and rat splicing structure (Fig. 7) . However, this strategy is different from that of ruminants (Bignon et al. 1997) and carp (San Martin et al. 2007 ). The PRL gene for primates, rodents, and ruminants/pigs diverged from each other at least 75 million years ago, while the pig PRL gene diverged from the ruminant PRL gene only 55 million years ago (Wallis 2000) . The divergence in the PRLR is presumed to have occurred at the same time (Forsyth & Wallis 2002) , given the co-evolution of PRL with its receptor (Li et al. 2005) . In fact, the phylogenetic tree comparing full-length PRLR-LF from birds, mammals, marsupials, and fish (Fig. 7E) shows an identical pattern of divergence to that of PRL (Wallis 2000) . If the splicing strategy of PRLR-SF that is unique to ruminants (Fig. 7D ) evolved under the same selection pressures as the PRLR-LF then it would be expected that pigs should have followed the ruminant PRLR-SF splicing strategy, rather than that used by humans and rodents. The 39 bp insert present in the ruminant PRLR-SF, as described by others (Bignon et al. 1997) , is in fact an alternative splicing strategy where a splice donor site at 40-41 bp upstream of exon 10 is used. Analysis of this region in the porcine PRLR indicates only 50% identity to the ruminant 39 bp insert sequence and an absence of this splice donor site. Similarly, teleost (tilapia and carp) PRLR-LF likely diverged from the hPRLR-LF 400 million years ago (Wallis 2000) but carp and humans are the only two species that include part of exon 10 in their PRLR-SF. Therefore, the evolution of splicing strategies to generate PRLR-SF appears not to have evolved under the same selection pressures acting on the PRLR-LF and PRL. The splicing strategy employed by species such as pigs that splice out exon 10 results in a PRLR-SF that still contains the WS motif and box 1 (Fig. 7B and D) . The WS motif is required for correct folding and cellular trafficking, and mutations in this region negatively impact PRL binding (Bole-Feysot et al. 1998) . Box 1, box 2, the region between boxes 1 and 2, and phosphorylation of three C-terminal tyrosine residues are required for full activation of Jak2 and Stat5 (DaSilva et al. 1994 , Lebrun et al. 1995a ,b, Pezet et al. 1997 . Apart from box 1, these regions are missing from most short isoforms, including the pPRLR-SF. While the sheep and rat PRLR-SF contain only box 1, they can activate Jak2 in vitro when high levels of Jak2 are present (Lebrun et al. 1995b , Bignon et al. 1999 , however, they are most likely unable to activate Jak2 in vivo (Devi et al. 2009 ). The hPRLR-SF1a, which has both box 1 and box 2, can weakly induce a 2 . 4 kb rat b-casein promoter via Jak2/Stat5 (Tan & Walker 2010) but not a shorter 300 bp promoter (Trott et al. 2003) . The parts of the PRLR required for activation of proliferation are less clear, apart from a requirement for box 1 (Bole-Feysot et al. 1998) . One short isoform from the mouse (PRLR-PR1) can activate mammary epithelial cell proliferation in vitro and in vivo (Das & Vonderhaar 1995 , Binart et al. 2003 . In contrast, the rat PRLR-SF inhibits the differentiative action, but not the proliferative effect, of mPRLR-LF in the mammary gland in vivo (Saunier et al. 2003) and is unable to transduce a proliferation signal in vitro (O'Neal & Yu-Lee 1994 , Chang et al. 1998 ). However, the rat PRLR-SF does mimic the mPRLR-PR1 in being able to downregulate Sp1 expression in rat luteal and uterine stroma cells (Devi et al. 2009 ). The rat PRLR-SF is homologous to the mPRLR-PR3 (93% identical) although the function of mPRLR-PR3 has not been studied despite its high levels of expression in mammary glands post puberty and during involution (Hovey et al. 2001) . Gibori et al.
have specifically studied the mPRLR-PR1 by generating mice that are transgenic for this isoform in a PRLRKO background. The resultant phenotype of these mice is striking in that they undergo accelerated follicular recruitment followed by massive follicular death that leads to premature ovarian failure (Halperin et al. 2008 ). Using this model, Halperin et al. (2008) identified that Foxo3 and Galt are two downstream targets of the mPRLR-PR1, where both of these are implicated during clinical ovarian failure in humans. This group also established that the mPRLR-PR1 mediates specific signaling pathways including downregulation of Sp1 target genes (Devi et al. 2009 ). Thus, while the level of pPRLR-SF expression in various target tissues may be important for its ability to block pPRLR-LF action via heterodimerization, it may be equally functional, independent of the pPRLR-LF. The binding affinity of pPRLR-LF for pPRL was similar to results obtained previously using human GH (K d Z1 . 75 nM; Trott et al. 2007) although it had a higher affinity for pPRL than did the pPRLR-SF. This is in contrast to hPRLR-LF, which has a similar affinity for hGH to that of hPRLR-SF1b, while hPRLR-SF1a binds hGH too weakly to determine the K d (Trott et al. 2003) . Both the pPRLR-SF and hPRLR-SF1b had significantly more receptor binding sites compared with their respective LF, likely because loss of the LF intracellular domain leads to decreased receptor internalization and degradation (Rozakis-Adcock & Kelly 1991).
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Exon 10 Figure 7 Comparison of the evolution of splicing strategies used to generate short isoforms of the prolactin receptor with the evolution of PRLR-LF sequences in different species. (A) The PRLR-LF in most species is generated by splicing together coding exons 3-10; in many fish species the long isoform comprises coding exons 2-9 (San Martin et al. 2007 , Fiol et al. 2009 ). In all species studied to date, the final exon is the longest. (B) One splicing strategy employed in pigs, humans, rats, and mice to generate a short isoform involves splicing from exon 9 to exon 11/12/13. The mouse is the only species with three short isoforms of the prolactin receptor that use either exon 11, 12, or 13 (Ormandy et al. 1998 ). (C) A second splicing strategy to generate a short isoform that is used by humans (SF1a) and carp (S1 and S2) involves splicing from exon 9 to a small section (ranging from 101 to 217 bp) at the 5 0 end of exon 10, then to exon 11. The genomic structure of the exons utilized by carp to generate short isoforms is unknown but judging from the sequence there exist both exons 11 and 12. (D) An alternative splicing strategy to generate a short isoform, employed by sheep, cows, and goats, involves splicing from exon 9 to a splice site 39 bp upstream of the start of exon 10 (the 39 bp insert). (E) Phylogenetic tree generated from alignment of the PRLR-LF aa sequences from 16 species, showing pig PRLR-LF is more closely related to ruminants than rodents or primates, while fish PRLR-LF sequences were the first to diverge from mammalian sequences. Tilapia has two PRLR genes, with PRLR1 being more similar than PRLR2 to the PRLR from other species (Fiol et al. 2009 ). WS, WS motif; I, box 1; II, box 2.
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The pPRLR-SF functions as a dominant negative with an effectiveness that is very similar to the rat PRLR-SF (Perrot-Applanat et al. 1997) . The pPRLR-SF does not appear to affect the level of pPRLR-LF protein and co-transfection of pPRLR-SF and pPRLR-LF increases the level of specific PRL binding. We therefore conclude that the pPRLR-SF probably exerts its dominant-negative effect by dimerizing with the pPRLR-LF, binding PRL, and inhibiting Jak2/Stat5 signaling. Previously, we found that hPRLR-SF1b was extremely effective as a dominant negative against the hPRLR-LF (Trott et al. 2003) . The efficacy of hPRLR-SF1b as a dominant negative may lie in its ability to accelerate hPRLR-LF mRNA degradation (Tan & Walker 2010) as well as its ability to heterodimerize with hPRLR-LF to block signaling (Tan et al. 2005) . In contrast, there is little data on the dominant-negative effectiveness of mPRLR-PR1 (Halperin et al. 2008) and no data exist for mPRLR-PR2, mPRLR-PR3, or the ovine, bovine, caprine, or carp short PRLR isoforms, although it has been suggested that the ovine PRLR-SF may act as a dominant negative (Cassy et al. 1998 ). Comparison of the intracellular domains of these short isoforms reveals that hPRLR-SF1b has the shortest intracellular domain (30 aa) while hPRLR-SF1a has the longest (118 aa), with the other species, including the pPRLR-SF, ranging from 38 to 57 aa. However, effectiveness as a dominant negative does not appear to correlate with intracellular domain length. When truncation mutants of rat PRLR intracellular domains are forced to heterodimerize with the intermediate form of the rat PRLR using GM-CSF chimeras, proliferation and signaling are completely inhibited regardless of the length of the mismatched intracellular domain (Chang et al. 1998) . Another mechanism by which the effectiveness of the pPRLR-SF as a dominant negative may be affected is through conformational changes to the ECD. The sequence and/or length of the intracellular domain can influence the conformation of the extracellular ligand-binding domain. For example, deleting part of or the entire intracellular domain of the rat PRLR-LF (Rozakis--Adcock & Kelly 1991) increases the PRL binding affinity compared with the intact PRLR-LF. Similarly, the hPRLR-SF1b is unable to dimerize with the hPRLR-SF1a, presumably because the intracellular domain sequences prevent the two ECDs binding PRL, even though both the receptors can dimerize with the hPRLR-LF and bind PRL (Tan et al. 2005) . Given these data, we hypothesize that the pPRLR-SF intracellular domain sequence affects its ECD and its ability to dimerize with the pPRLR-LF and determines its effectiveness as a dominant negative.
Although expression of pPRLR-SF mRNA was 1000 times lower than that of pPRLR-LF, we were able to detect comparable levels of pPRLR-SF and pPRLR-LF proteins in the mammary gland membranes. Previous studies utilizing 125 I-oPRL-labeled microsomal PRLR from pig mammary glands described a major binding unit of 35 kDa and a minor binding unit of 69 kDa (Sakai et al. 1985) . These sizes correspond to the predicted MW of the pPRLR-SF and pPRLR-LF respectively (Trott et al. 2007) , and most interestingly, the 35 kDa unit was the most abundant form (Sakai et al. 1985) . These data are consistent with our observations. A discrepency between PRLR-SF mRNA levels and protein levels has also been observed in carp, where the PRLR-SF is the predominant protein even though the PRLR-LF mRNA is more abundant than the PRLR-SF mRNA (San Martin et al. 2004 Martin et al. , 2007 . The discrepancy between pPRLR-SF mRNA and protein levels could be due to increased stability of the mRNA or protein relative to the pPRLR-LF. The reduced transcription of pPRLR-SF mRNA compared with pPRLR-LF could be due partly to the weaker polyadenylation signal, which is noncanonical and only used in 3% of human ESTs (Beaudoing et al. 2000) . A slower rate of turnover for the pPRLR-SF may reflect an absence of the ubiquitination signal DSGRGS, which is present at 348-353 aa of the pPRLR-LF, where phosphorylation of serine 349 leads to ubiquitination and degradation in lysozomes (Li et al. 2004) .
In conclusion, this study reports the identification of a pPRLR-SF that is encoded by exon 11 within the pPRLR gene. This pPRLR-SF is expressed most abundantly in several tissues known to be PRL targets in pigs. Despite a substantially lower transcript abundance, moderate levels of pPRLR-SF protein are expressed within the mammary glands of day 105 pregnant gilts. Based on our in vitro analyses, the pPRLR-SF acts as a dominant negative to the pPRLR-LF. Further analysis is required to fully characterize the role of this unique pPRLR during biological functions such as reproduction and lactation.
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